Clinical trials

Filters
Clear filters
1,718 trials
TrialSponsorPhaseStatusPrimary completion
ABTECT - MaintenanceNCT05535946ABVXPhase 3Active not recruiting2026-04-28Actual
Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease EventsNCT05537571SLNPhase 2Completed2024-01-11Actual
Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-Acting Insulin Aspart (I004) and NovoLog After Single-Dose Subcutaneous Administration to Healthy VolunteersNCT05539872AMPHPhase 2, Phase 3Completed2023-01-29Actual
A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX)NCT05540860EWTXPhase 2Active not recruiting2027-01Estimated
Effect of Mizagliflozin on Postprandial Glucose and Insulin in Post-Bariatric Hypoglycemia SubjectsNCT05541939VOGXPhase 2Completed2023-02-17Actual
Clinical Trial on Agitation in Alzheimer's DementiaNCT05543681IGC Pharma, LLCPhase 2Active not recruiting2026-11Estimated
Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary HyperparathyroidismNCT05543928OPKPhase 3Terminated2024-06-19Actual
A Phase 2 Study of ACR-368 in Endometrial AdenocarcinomaNCT05548296Acrivon TherapeuticsPhase 2Recruiting2027-05-30Estimated
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)NCT05549297Immunocore LtdPhase 3Recruiting2028-03Estimated
A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to SurgeryNCT05549505ARVNPhase 2Completed2024-07-13Actual
Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE)NCT05550207AXSMPhase 3Completed2024-11-27Actual
A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid TumorsNCT05551117MacroGenicsPhase 2Terminated2024-07-04Actual
A Study of Olezarsen Administered Subcutaneously to Participants With Severe HypertriglyceridemiaNCT05552326IONSPhase 3Completed2024-12-17Actual
Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum DisorderNCT05555615ACADPhase 2, Phase 3Terminated2025-02-14Actual
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease AgitationNCT05557409AXSMPhase 3Completed2024-11-21Actual
A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza ANCT05567783VIRPhase 2Terminated2023-05-05Actual
A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the BodyNCT05568095RCUSPhase 3Completed2026-08-28Actual
A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.NCT05568706ENTAPhase 2Completed2025-06-23Actual
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)NCT05571059Cumberland PharmaceuticalsPhase 2Recruiting2028-01Estimated
Safety and Efficacy Study of EVO101 Topical Cream in Atopic DermatitisNCT05579899EVMNPhase 2Completed2023-07-27Actual
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)NCT05580562Jazz PharmaceuticalsPhase 3Recruiting2028-06Estimated
Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia AreataNCT05589610EquilliumPhase 2Completed2024-03-26Actual
Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID ConditionsNCT05592418AIMPhase 2Completed2023-11-17Actual
Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Participants With a Kirsten Rat Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) MutationNCT05593328Cardiff OncologyPhase 2Completed2024-12-09Actual
A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque PsoriasisNCT05600036ALMSPhase 2Completed2023-06-29Actual
A Phase 1/2/3 Study of TSHA-102 Gene Therapy in Females With Rett Syndrome (REVEAL Pivotal Study)NCT05606614TSHAPhase 3Active not recruiting2031-06Estimated
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast CancerNCT05607004ATOSPhase 2Active not recruiting2026-11Estimated
Study to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations (FURVENT)NCT05607550AVBPPhase 3Active not recruiting2026-10-06Actual
A Study of Botensilimab and Balstilimab for the Treatment of Colorectal CancerNCT05608044AGENPhase 2Active not recruiting2027-09Estimated
A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).NCT05608681EPRXPhase 1, Phase 2Recruiting2026-12Estimated

ABTECT - Maintenance

ABVXActive not recruitingPrimary completion: 2026-04-28 · Actual
Trial details
Registry ID
NCT05535946
Phase
Phase 3

Primary completion marks the end of data collection for the main study measures, not a results publication date.